SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-20-000033
Filing Date
2020-02-26
Accepted
2020-02-26 08:30:31
Documents
3
Period of Report
2020-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-knewdirector.htm 8-K 29569
2 EXHIBIT 99.1 evfm991appointslisararickt.htm EX-99.1 17423
3 evfmappointslisararic_image1.jpg GRAPHIC 61097
  Complete submission text file 0001618835-20-000033.txt   132436
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 20653379
SIC: 2834 Pharmaceutical Preparations